Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats

• Egile Nagusiak: Sibel Koçak Yucel (Egilea), Hakki Arikan (Egilea), Halil Tugtepe (Egilea), Fulya Cakalagaoglu (Egilea), Serhan Tuglular (Egilea), Emel Akoglu (Egilea), Cetin Ozener (Egilea)
• Formatua: Liburua
• Argitaratua: Karger Publishers, 2014-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background/Aims: Continuous ambulatory peritoneal dialysis (CAPD) induces structural changes in the peritoneal membrane such as fibrosis, vasculopathy and angioneogenesis with a reduction in ultrafiltration capacity. Leukotriene (LT) receptor antagonists have been found to be effective to prevent fi...